Standard BioTools Inc. (LAB)
NASDAQ: LAB · Real-Time Price · USD
0.6276
-0.0798 (-11.28%)
Nov 16, 2026, 1:23 PM EST - Market open

Standard BioTools Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
24849265117593300
Market Cap Growth
-45.40%-24.44%271.28%89.12%-69.06%-32.58%
Enterprise Value
-187325375458322376
Last Close Price
0.711.281.752.211.173.92

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
3.315.777.161.650.952.30
PB Ratio
0.501.161.381.080.403.17
P/TBV Ratio
0.501.161.38---

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
-3.814.124.303.292.88

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.050.070.070.600.451.18
Net Debt / Equity Ratio
-0.78-0.37-0.56-0.10-0.280.88
Net Debt / EBITDA Ratio
11.401.903.740.350.75-1.30
Net Debt / FCF Ratio
6.621.901.730.360.68-1.45
Asset Turnover
0.140.140.200.300.290.44
Inventory Turnover
1.882.102.242.662.884.89
Quick Ratio
9.291.864.671.234.210.94
Current Ratio
9.754.195.701.454.811.45
Return on Equity (ROE)
-7.79%-13.13%-28.65%-37.99%-117.21%-50.71%
Return on Assets (ROA)
-5.03%-9.88%-11.63%-11.05%-18.61%-14.06%
Return on Capital Employed (ROCE)
-8.10%-20.30%-15.90%-29.50%-28.60%-29.90%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
54.45%-15.21%-21.32%-42.55%-204.90%-19.76%
FCF Yield
-23.51%-16.79%-23.30%-26.28%-100.45%-19.12%
Buyback Yield / Dilution
-2.75%-8.03%-346.24%-1.09%-3.32%-5.19%
SEC Filings: 10-K · 10-Q